EMD 128130 for the Treatment of Parkinson's Disease

NCT00009048 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

30

Enrollment

NIH

Sponsor class

Conditions

Parkinson's Disease

Interventions

DRUG: EMD 128130
DRUG: IV Levodopa

Sponsor

National Institute of Neurological Disorders and Stroke (NINDS)